Niagen Bioscience (OCD1) Q2 2024 Earnings Report
DE:OCD1 Q2 2024 EPS Results
- Actual EPS
- EUR 0.00
- Consensus EPS
- -EUR 0.02
- Beat/Miss
- Beat by +EUR 0.02
- One Year Ago EPS
- -EUR 0.03
DE:OCD1 Q2 2024 Revenue Results
- Actual Revenue
- EUR 20.36M
- Expected Revenue
- EUR 20.89M
- Beat/Miss
- Missed by -EUR 524.70K
- YoY Revenue Growth
- +11.89%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/07/2024
- Time
- After Close
- Conference Call
- Wednesday, August 7, 2024
DE:OCD1 Upcoming Earnings
Niagen Bioscience's next earnings date is estimated for November 4, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
DE:OCD1 Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:OCD1 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 04, 2026 | 2026 (Q3) | 0.00- | 0.04 | ― | ― |
| Aug 04, 2026 | 2026 (Q2) | 0.010.01 | 0.04 | -75.00% (-0.03) | |
| May 06, 2026 | 2026 (Q1) | 0.060.06 | 0.05 | 16.67% (+0.01) | |
| Mar 04, 2026 | 2025 (Q4) | 0.020.04 | 0.08 | -44.44% (-0.04) | |
| Nov 04, 2025 | 2025 (Q3) | 0.020.04 | 0.03 | 72.41% (+0.02) | |
| Aug 06, 2025 | 2025 (Q2) | 0.010.04 | 0 | ― | |
| May 07, 2025 | 2025 (Q1) | 0.020.05 | -0.01 | 700.00% (+0.06) | |
| Mar 04, 2025 | 2024 (Q4) | 0.020.08 | 0 | ― | |
| Oct 31, 2024 | 2024 (Q3) | 0.010.03 | 0 | 480.00% (+0.02) | |
| Aug 07, 2024 | 2024 (Q2) | -0.020.00 | -0.03 | 100.00% (+0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
